Allogene Therapeutics, Inc.
ALLO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737287
In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Allogene Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 172
- +9 vs. Q3 2025
- Shares held
- 162.7M
- +2.99M (+1.9%) vs. Q3 2025
- Total value
- $222.7M
- +$24.7M (+12.5%) vs. Q3 2025
- New holders
- 29
- 53 more added
- Sold out
- 20
- 46 more reduced
7 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 209 | $652.0M |
| Q1 2026 | 209 | $444.7M |
| Q4 2025 | 172 | $222.7M |
| Q3 2025 | 170 | $201.0M |
| Q2 2025 | 158 | $207.9M |
| Q1 2025 | 171 | $288.5M |
| Q4 2024 | 174 | $401.9M |
| Q3 2024 | 156 | $460.4M |
| Q2 2024 | 175 | $385.1M |
| Q1 2024 | 161 | $586.0M |
| Q4 2023 | 170 | $392.4M |
| Q3 2023 | 155 | $413.3M |
| Q2 2023 | 171 | $662.9M |
| Q1 2023 | 176 | $582.3M |
| Q4 2022 | 168 | $700.9M |
| Q3 2022 | 192 | $1.15B |
| Q2 2022 | 161 | $1.15B |
| Q1 2022 | 180 | $836.7M |
| Q4 2021 | 177 | $1.28B |
| Q3 2021 | 169 | $2.26B |
| Q2 2021 | 182 | $2.25B |
| Q1 2021 | 169 | $3.12B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Allogene Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Intech Investment Management LLC | 86,637 | $118.7K | 0.00% | +14,742+20.5% | Added |
| Susquehanna International Group, LLP | 91,253 | $125.0K | 0.00% | +22,753+33.2% | Added |
| Cerity Partners LLC | 97,909 | $134.1K | 0.00% | −368,823−79.0% | Reduced |
| Nwi Management LP | 100,000 | $137.0K | 0.01% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 103,740 | $142.1K | 0.00% | +103,740 | New |
| Squarepoint Ops LLC | 104,656 | $143.4K | 0.00% | −163,388−61.0% | Reduced |
| Deutsche Bank AG | 131,086 | $179.6K | 0.00% | −9,695−6.9% | Reduced |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 138,900 | $187.5K | 0.00% | 00.0% | Unchanged |
| HSBC Holdings PLC | 148,136 | $198.5K | 0.00% | +54,071+57.5% | Added |
| Nomura Asset Management International Inc. | 146,779 | $201.0K | 0.00% | +146,779 | New |
| Graham Capital Management, L.P. | 148,671 | $203.7K | 0.01% | −48,637−24.7% | Reduced |
| Partners Capital Investment Group, LLP | 161,597 | $221.4K | 0.01% | 00.0% | Unchanged |
| OpenArc Corporate Advisory, LLC | 162,984 | $223.3K | 0.00% | +162,984 | New |
| LPL Financial LLC | 170,750 | $233.9K | 0.00% | −6,750−3.8% | Reduced |
| Virtus Investment Advisers, Inc. | 176,178 | $241.4K | 0.07% | +94,902+116.8% | Added |
| Zacks Investment Management | 192,731 | $264.0K | 0.00% | −333,401−63.4% | Reduced |
| Harold Davidson & Associates Inc. | 194,753 | $266.8K | 0.12% | −100,679−34.1% | Reduced |
| Algert Global LLC | 196,400 | $269.1K | 0.00% | +196,400 | New |
| Wells Fargo & Company | 200,276 | $274.4K | 0.00% | +55,415+38.3% | Added |
| Rhumbline Advisers | 203,006 | $278.1K | 0.00% | −7,720−3.7% | Reduced |
| Bridgeway Capital Management, LLC | 250,000 | $342.5K | 0.01% | 00.0% | Unchanged |
| Nuveen, LLC | 272,007 | $372.6K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 273,384 | $374.5K | 0.00% | +219,754+409.8% | Added |
| Quadrature Capital Ltd | 274,416 | $375.9K | 0.00% | +36,479+15.3% | Added |
| Marshall Wace, LLP | 285,561 | $391.2K | 0.00% | +285,561 | New |
| Alliancebernstein L.P. | 296,498 | $406.2K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 405,843 | $556.0K | 0.00% | +3,972+1.0% | Added |
| TD Asset Management Inc | 414,074 | $567.3K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 435,267 | $596.3K | 0.00% | +59,209+15.7% | Added |
| Manufacturers Life Insurance Company, The | 484,622 | $637.8K | 0.00% | −5,355−1.1% | Reduced |
| XTX Topco Ltd | 476,307 | $652.5K | 0.02% | −297,896−38.5% | Reduced |
| Man Group plc | 526,106 | $720.8K | 0.00% | +244,054+86.5% | Added |
| Citigroup Inc | 591,952 | $811.0K | 0.00% | −2,147−0.4% | Reduced |
| Invesco Ltd. | 609,807 | $835.4K | 0.00% | +84,494+16.1% | Added |
| Gsa Capital Partners LLP | 613,998 | $841.0K | 0.07% | +431,119+235.7% | Added |
| Barclays PLC | 642,687 | $880.5K | 0.00% | +43,690+7.3% | Added |
| Morgan Stanley | 703,138 | $963.3K | 0.00% | −596,028−45.9% | Reduced |
| Raiffeisen Bank International AG | 900,000 | $1.18M | 0.02% | +450,000+100.0% | Added |
| BNP Paribas Arbitrage, SA | 900,424 | $1.23M | 0.00% | +6,110+0.7% | Added |
| Dimensional Fund Advisors LP | 957,816 | $1.31M | 0.00% | −1,132,937−54.2% | Reduced |
| JPMorgan Chase & Co | 979,112 | $1.34M | 0.00% | +70,387+7.7% | Added |
| Acadian Asset Management LLC | 995,141 | $1.36M | 0.00% | +461,332+86.4% | Added |
| Bank of America Corp | 1,007,328 | $1.38M | 0.00% | +33,008+3.4% | Added |
| Northern Trust Corp | 1,198,467 | $1.64M | 0.00% | −81,161−6.3% | Reduced |
| D. E. Shaw & Co., Inc. | 1,282,971 | $1.76M | 0.00% | +819,073+176.6% | Added |
| Charles Schwab Investment Management Inc | 1,355,809 | $1.86M | 0.00% | +190,529+16.4% | Added |
| DAFNA Capital Management LLC | 1,380,118 | $1.89M | 0.44% | 00.0% | Unchanged |
| UBS Group AG | 1,389,593 | $1.90M | 0.00% | −2,181,564−61.1% | Reduced |
| AQR Capital Management LLC | 1,429,247 | $1.96M | 0.00% | −424,307−22.9% | Reduced |
| FMR LLC | 1,445,761 | $1.98M | 0.00% | +734,801+103.4% | Added |
| Millennium Management LLC | 1,841,307 | $2.52M | 0.00% | −1,548,719−45.7% | Reduced |
| Standard Life Aberdeen plc | 2,086,332 | $2.86M | 0.00% | +504,067+31.9% | Added |
| Jane Street Group, LLC | 2,160,383 | $2.96M | 0.00% | +944,610+77.7% | Added |
| Renaissance Technologies LLC | 2,187,084 | $3.00M | 0.00% | −706,728−24.4% | Reduced |
| Goldman Sachs Group Inc | 2,289,458 | $3.14M | 0.00% | +1,085,750+90.2% | Added |
| Candriam Luxembourg S.C.A. | 2,305,644 | $3.16M | 0.02% | +2,305,644 | New |
| Kalehua Capital Management LLC | 2,546,129 | $3.49M | 3.45% | +2,546,129 | New |
| State Street Corp | 2,761,400 | $3.78M | 0.00% | +6,022+0.2% | Added |
| Two Sigma Advisers, LP | 2,890,200 | $3.96M | 0.01% | +108,600+3.9% | Added |
| Wildcat Capital Management, LLC | 2,920,787 | $4.00M | 2.93% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,209,275 | $4.40M | 0.00% | −468,199−12.7% | Reduced |
| Two Sigma Investments, LP | 3,423,441 | $4.69M | 0.01% | +39,797+1.2% | Added |
| Woodline Partners LP | 3,500,499 | $4.80M | 0.02% | −860,109−19.7% | Reduced |
| Frazier Life Sciences Management, L.P. | 3,868,750 | $5.30M | 0.14% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 3,932,910 | $5.39M | 0.00% | +99,025+2.6% | Added |
| Patient Square Capital LP | 4,963,756 | $6.80M | 1.46% | +1,982,360+66.5% | Added |
| Primecap Management Co | 8,139,840 | $11.2M | 0.01% | +1,060,532+15.0% | Added |
| Vanguard Group Inc | 9,251,609 | $12.7M | 0.00% | +230,839+2.6% | Added |
| Citadel Advisors LLC | 12,111,420 | $16.6M | 0.01% | −1,860,137−13.3% | Reduced |
| BlackRock, Inc. | 17,676,029 | $24.2M | 0.00% | +161,355+0.9% | Added |
| TPG GP A, LLC | 18,716,306 | $25.6M | 0.95% | 00.0% | Unchanged |
| Pfizer Inc | 22,032,040 | $30.2M | 12.76% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 0 | $0 | 0.00% | −546,119−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −146,779−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −85,930−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −39,677−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −37,401−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −36,446−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −26,635−100.0% | Sold out |
| Brighton Jones LLC | 0 | $0 | 0.00% | −25,168−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −18,602−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −15,930−100.0% | Sold out |
| Seven Mile Advisory | 0 | $0 | 0.00% | −14,434−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −11,993−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −11,740−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Axxcess Wealth Management, LLC | 0 | $0 | 0.00% | −10,208−100.0% | Sold out |
| DLK Investment Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −4,069−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −837−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −827−100.0% | Sold out |
| Hoey Investments, Inc | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Vida Ventures Advisors, LLC | – | – | – | – | Not filed |
| Moloney Securities Asset Management, LLC | – | – | – | – | Not filed |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| CIBC Bancorp USA Inc. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |
| Point72 Europe (London) LLP | – | – | – | – | Not filed |
| West Oak Capital, LLC | – | – | – | – | Not filed |